glp-1 slidell and Anesthesia: Considerations and Cautions for CRNAs Louisiana's Best Virtual Weight Loss

Obesity is a chronic condition, and GLP-1 medications treat the underlying biology

Signalingmetabolic crosstalk in CRC: a dual-track mechanism of resistance to targeted therapy Precision therapies targeting EGFR, BRAF, and MEK have offered new hope for patients with CRC [74]

Int J Mol Med 41(4):20792085

The Asp-glutamate transporter SLC1A3 is closely associated with the effect of ETC inhibitors, and the SLC1A3 site is amplified in subclusters of non-glial epithelial tumors and thus against aspartic restriction

Supplementary material The Supplementary Material for this article can be found online at: References 1 VestergaardP